CXCL13 and myeloid sarcoma: To explore the specific cytokines involved in BSCB damage, peripheral blood serum samples were collected from eight clinical MS patients for protein mass spectrometry analysis, and the data indicated elevated levels of CXCL13 in MS patients (Figure 2A, Table S1, Supporting Information).